DOI : 10.1055/s-00000059

Pneumologie

Issue S 01 · Volume 70 · February 2016 DOI: 10.1055/s-006-30929


57. Kongress der Deutschen Gesellschaft für Pneumologie und Beatmungsmedizin e.V.
Leipzig, 2.–5. 3. 2016

Kongresspräsident: Prof. Dr. med. Hubert Wirtz, Leipzig – Kongresssekretär: Dr. med. Jens Bräunlich, Leipzig
Abstracts (HTML) List of Authors
P384
D'Urzo, A; Singh, D; Kerwin, E; Lakkis, H; Chuecos, F; de Miquel, G; Grund, T: Efficacy and safety of aclidinium/formoterol fixed-dose combination in patients with moderate to severe airflow obstruction, stratified by severity
P364
Vogelmeier, C; Paggiaro, P; Dorca, J; Sliwinski, P; Mallet, M; Kirsten, AM; Seoane, B; Segarra, RM; Leselbaum, A; Gil, EG: Efficacy of aclidinium/formoterol fixed-dose combination versus salmeterol/fluticasone in COPD
P251
Koczulla, R; Calverley, P; Anzueto, A; Dahl, R; Müller, A; Fowler, A; Metzdorf, N; Wise, R; Dusser, D: T Safety And Performance In Respimat® (TIOSPIR™): Safety And Efficacy In Patients With T HH® Use At Baseline
P249
Köhnlein, T; Buhl, R; Tetzlaff, K; Korducki, L; Vogelmeier, C; McGarvey, L: Pooled Safety Analysis Of Adjudicated Serious Adverse Events With The Fixed-Dose Combination Of Tiotropium + Olodaterol
P248
Priegnitz, C; Ferguson, GT; Pizzichini, E; Flezar, M; Grönke, L; Korducki, L: The fixed-dose combination of tiotropium + olodaterol has a rapid onset of action in patients with COPD
P246
Watz, H; Derom, E; Korn, S; Hamilton, A; Amatto, VC; Zhao, Y; Maltais, F: Efficacy of tiotropium and olodaterol fixed-dose combination in patients with COPD on beta-blockers
P247
Watz, H; Ferguson, GT; Grönke, L; Voss, F; Abrahams, R; Buhl, R: Inhaled Corticosteroid Plus Long-Acting Beta2-Agonist Therapy Is Overused In The Treatment Of Patients With Chronic Obstructive Pulmonary Disease: Post Hoc Analyses Of Two 1-Year Studies
P232
Greulich, T; Buhl, R; Abrahams, R; Grönke, L; Korducki, L; Flezar, M; Ferguson, GT: Tiotropium Plus Olodaterol Fixed-Dose Combination Therapy Provides Lung Function Benefits When Compared With Tiotropium Alone, Irrespective Of Prior Treatment With A Long-Acting Bronchodilator: Post Hoc Analyses Of Two 1-Year-Studies
P231
Haensel, M; Korn, S; Buhl, R; Grönke, L; Korducki, L; Amatto, VC; Ferguson, GT; Abrahams, R: Analysis Of The Efficacy And Safety Of The Fixed-Dose Combination Of Tiotropium + Olodaterol In Patients With COPD By Initial Disease Severity
P218
Killian, PH; Afisi Segun, I; Huisman, EL; Punekar, YS; Karabis, A: Effektivität von Umeclidinium/Vilanterol im Vergleich zu anderen LAMA/LABA-Kombinationen in der Erhaltungstherapie der COPD: Systematischer Review und Netzwerk-Metaanalyse
P219
Glaab, T; Buhl, R; Abrahams, R; Grönke, L; Voss, F; Flezar, M; Ferguson, GT: Tiotropium + Olodaterol Fixed-Dose Combination Therapy Provides Lung-Function Benefits Compared With Tiotropium Alone In Patients With GOLD A/B And C/D Chronic Obstructive Pulmonary Disease: Post Hoc Analyses Of Two 1-Year Studies
P215
Singh, D; D'Urzo, A; Donohue, J; Chuecos, F; Leselbaum, A; Gil, EG; Teubner, J: Lungenfunktion unter Fixdosis-Kombination aus Aclidinium/Formoterol: Gepoolte Analyse aus zwei Phase-III-Studien über COPD
P205
Watz, H; Mailänder, C; Kirsten, AM: Effekte von Indacaterol/Glycopyrronium auf Lungenfunktion und die gemessene körperliche Aktivität von Patienten mit moderater bis schwerer COPD
P197
Watz, H; Mailänder, C; Kirsten, AM: Überlegenheit von Glycopyrronium im Vergleich zu Tiotropium in der früh-einsetzenden Bronchodilatation von Patienten mit moderater bis schwerer COPD – Die FAST Studie